TY - JOUR
T1 - Comparison of cryoprecipitate preparation methods
T2 - changes in plasma fibrinogen levels
AU - Ishihara, Yuya
AU - Matsuura, Hideaki
AU - Miyawaki, Takeshi
AU - Kojima, Hayato
AU - Ozeki, Takato
AU - Hasegawa, Mai
AU - Fujii, Sumie
AU - Miura, Yasuo
N1 - Publisher Copyright:
© 2025 Société francophone de transfusion sanguine (SFTS)
PY - 2026/2
Y1 - 2026/2
N2 - Background and Objectives: Reports on the changes in plasma fibrinogen levels in patients receiving cryoprecipitates synthesized using different methods are lacking. Therefore, we investigated these changes in patients who underwent cardiovascular surgery. Materials and Methods: We included 309 patients who underwent cardiovascular surgery and received 12 cryoprecipitate units between February 2020 and March 2024 and 204 patients were selected by propensity score matching. The cryoprecipitates were prepared using two methods. Fresh frozen plasma (FFP) was thawed at 2 to 6 °C for 24 h and centrifuged to remove the supernatant in the one-step method, whereas FFP was thawed, refrozen at −20 °C, and subsequently rethawed in the two-step method. We investigated the association between different cryoprecipitate preparation methods and ICU admission for ≥1 week, with in-hospital mortality considered as a competing risk in the analysis. In addition, we evaluated the changes in plasma fibrinogen levels before and after cryoprecipitate administration. Results: Baseline plasma fibrinogen levels were significantly higher in the two-step method group than in the one-step method group. Differences in cryoprecipitate preparation methods were not significantly associated with ICU admission for ≥1 week, in the analysis that considered in-hospital mortality as a competing risk (P = 0.93). The increase in plasma fibrinogen levels after cryoprecipitate administration was significantly higher with the two-step method than with the one-step method (36 mg/dL vs. 51 mg/dL, P = 0.020). Conclusion: The cryoprecipitates synthesized using the two-step method showed a higher increase in plasma fibrinogen levels than those prepared using the one-step method. These findings may help guide appropriate transfusion protocols by confirming intraoperative plasma fibrinogen levels.
AB - Background and Objectives: Reports on the changes in plasma fibrinogen levels in patients receiving cryoprecipitates synthesized using different methods are lacking. Therefore, we investigated these changes in patients who underwent cardiovascular surgery. Materials and Methods: We included 309 patients who underwent cardiovascular surgery and received 12 cryoprecipitate units between February 2020 and March 2024 and 204 patients were selected by propensity score matching. The cryoprecipitates were prepared using two methods. Fresh frozen plasma (FFP) was thawed at 2 to 6 °C for 24 h and centrifuged to remove the supernatant in the one-step method, whereas FFP was thawed, refrozen at −20 °C, and subsequently rethawed in the two-step method. We investigated the association between different cryoprecipitate preparation methods and ICU admission for ≥1 week, with in-hospital mortality considered as a competing risk in the analysis. In addition, we evaluated the changes in plasma fibrinogen levels before and after cryoprecipitate administration. Results: Baseline plasma fibrinogen levels were significantly higher in the two-step method group than in the one-step method group. Differences in cryoprecipitate preparation methods were not significantly associated with ICU admission for ≥1 week, in the analysis that considered in-hospital mortality as a competing risk (P = 0.93). The increase in plasma fibrinogen levels after cryoprecipitate administration was significantly higher with the two-step method than with the one-step method (36 mg/dL vs. 51 mg/dL, P = 0.020). Conclusion: The cryoprecipitates synthesized using the two-step method showed a higher increase in plasma fibrinogen levels than those prepared using the one-step method. These findings may help guide appropriate transfusion protocols by confirming intraoperative plasma fibrinogen levels.
KW - Cardiovascular surgery
KW - Cryoprecipitate
KW - Plasma fibrinogen
KW - Preparation methods
UR - https://www.scopus.com/pages/publications/105020973452
UR - https://www.scopus.com/pages/publications/105020973452#tab=citedBy
U2 - 10.1016/j.tracli.2025.10.003
DO - 10.1016/j.tracli.2025.10.003
M3 - Article
C2 - 41135864
AN - SCOPUS:105020973452
SN - 1246-7820
VL - 33
SP - 16
EP - 24
JO - Transfusion Clinique et Biologique
JF - Transfusion Clinique et Biologique
IS - 1
ER -